1. Aitken, M. L., Berndt, E. R., Bosworth, B., Cockburn, I. M., Frank, R., Kleinrock, M., & Shapiro, B. T. (2013). The regulation of prescription drug competition and market responses: Patterns in prices and sales following loss of exclusivity NBER Working Paper Series. Cambridge, MA: National Bureau of Economic Research
2. Berndt, E. R., & Aitken, M. L. (2011). Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation. International Journal of the Economics of Business, 18(2), 177–201.
3. Center for Medicare and Medicaid Services (2013). National health expenditure (NHE) Amounts by type of expenditure and source of funds: Calendar years 1965–2022. Retrieved May 26, 2015, from http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsProjected.html .
4. Centers for Medicare & Medicaid Services. (2012). Medicaid program: Eligibility changes under the Affordable Care Act of 2010 (CMS-2349-F). Baltimore, MD: Centers for Medicare & Medicaid Services. Retrieved May 26, 2015, from http://www.medicaid.gov/AffordableCareAct/downloads/CMS-2349-F-RegulatoryImpactAnalysis.pdf .
5. Centers for Medicare & Medicaid Services. (2014). Accuracy analysis of the short-term (11-year) national health expenditure projections. Retrieved July 04, 2014, from http://www.cms.gov/NationalHealthExpendData/downloads/ProjectionAccuracy.pdf